ASCRS 2024: Centricity Vision’s new ZEPTOLink IOL positioning system
At this year’s ASCRS meeting in Boston, Massachusetts, Leonard Borrmann, CEO at Centricity Vision, about the company’s new product ZEPTOLink, including first-in-human data.
At this year’s ASCRS meeting in Boston, Massachusetts, Leonard Borrmann, CEO at Centricity Vision, about the company’s new product ZEPTOLink, including first-in-human data.
Vision rehabilitation makes it easier for people with vision impairment or low vision to do everyday activities.
Sight Sciences received a positive jury trial verdict of $34 million in a patent infringement case against Alcon and its Hydrus microstent, according to a…
Unveiling the Power List – a comprehensive ranking of the top 100 most influential ophthalmologists worldwide. Browse the list to find leading eye care experts,…
Researchers found the model demonstrated “near-perfect” detection capabilities.
To describe a pilot study on the use of single-session, high-dose-rate, FDA-cleared, yttrium-90 (90Y) plaque brachytherapy for iris and iridociliary melanoma.
Purpose: To detect structural and functional changes in children with intermittent exotropia using optical coherence tomography, pattern electroretinography (ERG), and multifocal ERG. Methods: The study…
Unveiling the Power List – a comprehensive ranking of the top 100 most influential ophthalmologists worldwide. Browse the list to find leading eye care experts,…
A dilated eye exam is the only way to check for eye diseases early on, when they’re easier to treat. Learn more about dilated eye…
To determine the clinical characteristics of familial exudative vitreoretinopathy (FEVR) associated with or without pathogenic variants of the Norrin/β-catenin genes.
Unveiling the Power List – a comprehensive ranking of the top 100 most influential ophthalmologists worldwide. Browse the list to find leading eye care experts,…